Adjuvant everolimus after surgery for renal cell carcinoma (EVEREST): a double-blind, placebo-controlled, randomised, phase 3 trial
- Resource Type
- Article
- Authors
- Ryan, Christopher W ; Tangen, Catherine M; Heath, Elisabeth I; Stein, Mark N; Meng, Maxwell V; Alva, Ajjai S; Pal, Sumanta K; Puzanov, Igor; Clark, Joseph I; Choueiri, Toni K; Agarwal, Neeraj; Uzzo, Robert G; Haas, Naomi B; Synold, Timothy W; Plets, Melissa; Vaishampayan, Ulka N; Shuch, Brian M; Thompson, Ian M, Jr; Lara, Primo N, Jr
- Source
- In The Lancet 23-29 September 2023 402(10407):1043-1051
- Subject
- Primary Research
Articles
- Language
- ISSN
- 0140-6736